𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B

✍ Scribed by Andreas Erhardt; Ulf Reineke; Dirk Blondin; Wolfram Hubert Gerlich; Ortwin Adams; Tobias Heintges; Claus Niederau; Dieter Häussinger

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
230 KB
Volume
31
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in the X region and core promo
Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B
✍ Charles Hannoun; Peter Horal; Kim Krogsgaard; Magnus Lindh 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract Therapy for chronic hepatitis B with interferon‐α (IFN) may result in viral clearance and hepatitis B e seroconversion in 30–40% of patients. It is still unclear whether viral genetic variability influences response rates. However, certain core promoter mutations were recently associate

Prediction of response to treatment of c
Prediction of response to treatment of chronic hepatitis B with pegylated interferon in the Philippines
✍ Dorothy M. Agdamag; Seiji Kageyama; Prisca S. Leaño; Rontgene M. Solante; Elizab 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

## Abstract The response marker for interferon has not been investigated fully for hepatitis B viruses (HBVs) in the Philippines where novel subtypes B5 and C5 were recognized recently. The prediction parameters for interferon treatment were assessed, with emphasis on the mutation patterns in the b

Precore/core promoter mutations and geno
Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis
✍ Chun-Jen Liu; Jia-Horng Kao; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract The association of precore stop codon mutation (A1896), dinucleotide mutation (T1762/A1764) in the basic core promoter of hepatitis B virus (HBV) genome, and genotype of HBV with fulminant or subfulminant hepatitis remains controversial. We studied HBV genotypes as well as mutations in

Cellular immunity to hepatitis C virus c
Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C
✍ Juan-José Lasarte; Marta García-Granero; Ascensión López; Noelia Casares; Nicolá 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

To investigate the involvement of T-cell response against hepatitis C virus (HCV) antigens in viral clearance after interferon therapy, we measured interleukin-2 (IL-2) production by peripheral mononuclear cells in response to HCV core in patients with chronic hepatitis C. In a cohort of 43 patients

Hepatic and extrahepatic HCV RNA strands
Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: Different patterns of response to interferon treatment
✍ Beatriz Gil; Cheng Qian; Jose I. Riezu-Boj; Maria P. Civeira; Jesús Prieto 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

We investigated the presence of positive (genomic) and negative (replicative intermediate) hepatitis C virus RNA strands in liver, peripheral mononuclear cells and serum from patients with chronic hepatitis C using a selective and semiquantitative polymerase chain reaction procedure. Negative and po